Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients

Maria Miguel, Ms Sampaio, Hung Tien Kuo, Neda Poommipanit, Paul Martin, Suphamai Bunnapradist

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Preexisting hepatitis C virus (HCV) infection is implicated in diminished patient and graft survivals in renal transplant recipients. The impact of HCV infection on patient and graft survival in simultaneous pancreas-kidney transplantations is unclear. We evaluated the effect of preexisting HCV infection on patient and graft survival in simultaneous pancreas-kidney transplant (SPKT) recipients in the United States. Methods: Using the Organ Procurement and Transplant Network/United Network for Organ Sharing database as of March 2009, adult primary SPKT recipients transplanted from 1995 to 2008 were studied. We stratified recipients based on pretransplant HCV status as HCV positive (HCV+) or HCV negative (HCV-). Overall kidney graft, pancreas graft, and patient survival were compared. Results: A total of 10,809 adults received primary SPKT, of which 350 (3.2%) were HCV+. Less than 2% of the HCV+ recipients received organs from HCV+ donors. There were no significant differences in baseline donor and recipient characteristics between groups. Rates of acute kidney rejection at 1 year were similar: 22.9% for HCV+ and 23.0% for HCV-recipients (P=0.49). There was no difference in serum creatinine between groups up to 3 years. After controlling for confounding factors, HCV positivity was not associated with worsened overall kidney graft (hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.61-1.03), pancreas graft (HR 0.80, 95% CI 0.63-1.00), or patient survival (HR 0.78, 95% CI 0.56-1.08). ConclusionS: Only 3.2% of SPKT recipients had preexisting HCV infection. Preexisting HCV infection had no significant impact on kidney graft, pancreas graft, or patient survival.

Original languageEnglish
Pages (from-to)61-67
Number of pages7
JournalTransplantation
Volume90
Issue number1
DOIs
StatePublished - Jul 15 2010

Fingerprint

Hepatitis C Antibodies
Hepacivirus
Pancreas
Kidney
Virus Diseases
Transplants
Graft Survival
Transplant Recipients
Confidence Intervals
Tissue Donors
Pancreas Transplantation
Tissue and Organ Procurement
Survival

Keywords

  • Hepatitis C
  • Kidney transplant
  • Outcomes.
  • Pancreas transplant
  • Survival

ASJC Scopus subject areas

  • Transplantation

Cite this

Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients. / Miguel, Maria; Sampaio, Ms; Kuo, Hung Tien; Poommipanit, Neda; Martin, Paul; Bunnapradist, Suphamai.

In: Transplantation, Vol. 90, No. 1, 15.07.2010, p. 61-67.

Research output: Contribution to journalArticle

Miguel, Maria ; Sampaio, Ms ; Kuo, Hung Tien ; Poommipanit, Neda ; Martin, Paul ; Bunnapradist, Suphamai. / Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients. In: Transplantation. 2010 ; Vol. 90, No. 1. pp. 61-67.
@article{2bf7dd98354d433ea9a172f7fce0cd6a,
title = "Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients",
abstract = "Background: Preexisting hepatitis C virus (HCV) infection is implicated in diminished patient and graft survivals in renal transplant recipients. The impact of HCV infection on patient and graft survival in simultaneous pancreas-kidney transplantations is unclear. We evaluated the effect of preexisting HCV infection on patient and graft survival in simultaneous pancreas-kidney transplant (SPKT) recipients in the United States. Methods: Using the Organ Procurement and Transplant Network/United Network for Organ Sharing database as of March 2009, adult primary SPKT recipients transplanted from 1995 to 2008 were studied. We stratified recipients based on pretransplant HCV status as HCV positive (HCV+) or HCV negative (HCV-). Overall kidney graft, pancreas graft, and patient survival were compared. Results: A total of 10,809 adults received primary SPKT, of which 350 (3.2{\%}) were HCV+. Less than 2{\%} of the HCV+ recipients received organs from HCV+ donors. There were no significant differences in baseline donor and recipient characteristics between groups. Rates of acute kidney rejection at 1 year were similar: 22.9{\%} for HCV+ and 23.0{\%} for HCV-recipients (P=0.49). There was no difference in serum creatinine between groups up to 3 years. After controlling for confounding factors, HCV positivity was not associated with worsened overall kidney graft (hazard ratio [HR] 0.80, 95{\%} confidence interval [CI] 0.61-1.03), pancreas graft (HR 0.80, 95{\%} CI 0.63-1.00), or patient survival (HR 0.78, 95{\%} CI 0.56-1.08). ConclusionS: Only 3.2{\%} of SPKT recipients had preexisting HCV infection. Preexisting HCV infection had no significant impact on kidney graft, pancreas graft, or patient survival.",
keywords = "Hepatitis C, Kidney transplant, Outcomes., Pancreas transplant, Survival",
author = "Maria Miguel and Ms Sampaio and Kuo, {Hung Tien} and Neda Poommipanit and Paul Martin and Suphamai Bunnapradist",
year = "2010",
month = "7",
day = "15",
doi = "10.1097/TP.0b013e3181e17032",
language = "English",
volume = "90",
pages = "61--67",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Influence of preexisting hepatitis C virus antibody positivity in simultaneous pancreas-kidney transplant recipients

AU - Miguel, Maria

AU - Sampaio, Ms

AU - Kuo, Hung Tien

AU - Poommipanit, Neda

AU - Martin, Paul

AU - Bunnapradist, Suphamai

PY - 2010/7/15

Y1 - 2010/7/15

N2 - Background: Preexisting hepatitis C virus (HCV) infection is implicated in diminished patient and graft survivals in renal transplant recipients. The impact of HCV infection on patient and graft survival in simultaneous pancreas-kidney transplantations is unclear. We evaluated the effect of preexisting HCV infection on patient and graft survival in simultaneous pancreas-kidney transplant (SPKT) recipients in the United States. Methods: Using the Organ Procurement and Transplant Network/United Network for Organ Sharing database as of March 2009, adult primary SPKT recipients transplanted from 1995 to 2008 were studied. We stratified recipients based on pretransplant HCV status as HCV positive (HCV+) or HCV negative (HCV-). Overall kidney graft, pancreas graft, and patient survival were compared. Results: A total of 10,809 adults received primary SPKT, of which 350 (3.2%) were HCV+. Less than 2% of the HCV+ recipients received organs from HCV+ donors. There were no significant differences in baseline donor and recipient characteristics between groups. Rates of acute kidney rejection at 1 year were similar: 22.9% for HCV+ and 23.0% for HCV-recipients (P=0.49). There was no difference in serum creatinine between groups up to 3 years. After controlling for confounding factors, HCV positivity was not associated with worsened overall kidney graft (hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.61-1.03), pancreas graft (HR 0.80, 95% CI 0.63-1.00), or patient survival (HR 0.78, 95% CI 0.56-1.08). ConclusionS: Only 3.2% of SPKT recipients had preexisting HCV infection. Preexisting HCV infection had no significant impact on kidney graft, pancreas graft, or patient survival.

AB - Background: Preexisting hepatitis C virus (HCV) infection is implicated in diminished patient and graft survivals in renal transplant recipients. The impact of HCV infection on patient and graft survival in simultaneous pancreas-kidney transplantations is unclear. We evaluated the effect of preexisting HCV infection on patient and graft survival in simultaneous pancreas-kidney transplant (SPKT) recipients in the United States. Methods: Using the Organ Procurement and Transplant Network/United Network for Organ Sharing database as of March 2009, adult primary SPKT recipients transplanted from 1995 to 2008 were studied. We stratified recipients based on pretransplant HCV status as HCV positive (HCV+) or HCV negative (HCV-). Overall kidney graft, pancreas graft, and patient survival were compared. Results: A total of 10,809 adults received primary SPKT, of which 350 (3.2%) were HCV+. Less than 2% of the HCV+ recipients received organs from HCV+ donors. There were no significant differences in baseline donor and recipient characteristics between groups. Rates of acute kidney rejection at 1 year were similar: 22.9% for HCV+ and 23.0% for HCV-recipients (P=0.49). There was no difference in serum creatinine between groups up to 3 years. After controlling for confounding factors, HCV positivity was not associated with worsened overall kidney graft (hazard ratio [HR] 0.80, 95% confidence interval [CI] 0.61-1.03), pancreas graft (HR 0.80, 95% CI 0.63-1.00), or patient survival (HR 0.78, 95% CI 0.56-1.08). ConclusionS: Only 3.2% of SPKT recipients had preexisting HCV infection. Preexisting HCV infection had no significant impact on kidney graft, pancreas graft, or patient survival.

KW - Hepatitis C

KW - Kidney transplant

KW - Outcomes.

KW - Pancreas transplant

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=77954622474&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954622474&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e3181e17032

DO - 10.1097/TP.0b013e3181e17032

M3 - Article

C2 - 20463638

AN - SCOPUS:77954622474

VL - 90

SP - 61

EP - 67

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -